Lupin Inaugurates New Headquarters in Bridgewater, NJ

Lupin Limited recently inaugurated new corporate offices at 100 Somerset Corporate Blvd in Bridgewater, New Jersey with a ribbon-cutting ceremony attended by Governor Phil Murphy and Somerset County Commissioner Deputy Director Melonie Marano, alongside Lupin executives.

The approximately 18,000 square foot office will accommodate various corporate functions, including commercial, HR, finance, legal, marketing, business development, and R&D.

“New Jersey is a stronghold for the biopharmaceutical industry, and we have been proud members of the community since 2016,” said Vinita Gupta, CEO, Lupin. “Our operations in the state, including corporate offices, manufacturing and research facilities, have been an important part of our U.S. growth and expansion. This foundation enables us to drive innovation and provide access to affordable, high-quality medications nationwide. We deeply appreciate the partnership and support of New Jersey’s leadership, which has been instrumental for our ongoing development, both within the state and throughout the country.”

“Increasing our presence in New Jersey allows us to scale our operations, grow our workforce, and contribute meaningfully to the community,” added Spiro Gavaris, President, U.S. Generics, Lupin. “Our NJ-based workforce now exceeds 300 employees, and we have plans to continue to grow. The state offers a robust pool of talented professionals across all facets of the life sciences sector, and we look forward to creating opportunities for their contributions.”

Lupin has been making significant investments in the U.S. Most recently, it announced plans to build a manufacturing facility in Coral Springs, Florida to anchor U.S. production of critical respiratory therapies.